Vaginal atrophy is a condition that can negatively impact the quality of life of many postmenopausal women. Local exogenous estrogen therapy can effectively alter the anatomic and pathophysiologic ...
Expert Rev of Obstet Gynecol. 2013;8(5):457-465. While treatments for vulvovaginal atrophy have often focused on the vagina, it is critical to address care for the vulvar vestibule as well. The ...
Bachmann G, Lobo RA, Gut R, Nachtigall L, Notelovitz M. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Obstet Gynecol 2008;111:67 ...
MELBOURNE, Australia and SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ATHE) (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to ...
MELBOURNE, Australia and SAN FRANCISCO, July 28, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying ...
Symptoms of vaginal atrophy are generally progressive over time due to the natural decline of estrogen levels with age, and they will not resolve without treatment. It is important to identify signs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results